Both in Surgical Instruments
PROCEPT BioRobotics vs Tandem Diabetes Care
Over the past year PRCT returned −43.7% and TNDM returned +30.0%; their daily moves had a correlation of 0.29.
PRCT −43.7% TNDM +30.0%Growth of $1, one year, split-adjusted
| Metric | PRCT | TNDM |
|---|---|---|
| Price | $19.44 | $18.67 |
| Market cap | $1.11B | $1.30B |
| Today | +1.25% | −2.30% |
| 1 month | +13.3% | +13.2% |
| 6 months | −21.7% | −6.0% |
| Year to date | −38.2% | −15.1% |
| 1 year | −43.5% | +28.0% |
| Revenue growth (YoY) | +19.3% | +5.8% |
| Gross margin | 66.0% | 56.9% |
| Net margin | −28.4% | −8.3% |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | 1.2× |
| Net cash | $176.2M | -$146.6M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 50.1% |
| Short % of float | 14.1% | 21.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).